Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (

Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (

Item

http://www.wikidata.org/entity/Q33835519

Q33835519

about

Intensive versus conventional glycaemic control for treating diabetic foot ulcers Ultra-long acting insulin versus long-acting insulin for type 1 diabetes mellitus Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus Standards of medical care in diabetes--2012 Hyperglycemia-Induced Changes in Hyaluronan Contribute to Impaired Skin Wound Healing in Diabetes: Review and Perspective Secondary stroke prevention: challenges and solutions Long-term Outcomes in Youths with Diabetes Mellitus Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems: a position statement ...Biomarkers in diabetes: hemoglobin A1c, vascular and tissue markers Insulin sensitivity and complications in type 1 diabetes: New insights Type 1 diabetes The unfolded protein response and diabetic retinopathy Diabetes care for emerging adults: transition from pediatric to adult diabetes care systems Clinical requirements for closed-loop control systems.Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report Standards of medical care in diabetes--2013 Presence and Risk Factors for Glaucoma in Patients with Diabetes.In silico design of optimal ratio for co-administration of pramlintide and insulin in type 1 diabetes.Adherence decision making in the everyday lives of emerging adults with type 1 diabetes.Concordance of retinopathy and nephropathy over time in Type 1 diabetes: an analysis of data from the Diabetes Control and Complications Trial.Using uncertain data from body-worn sensors to gain insight into type 1 diabetes.Targeting Diabetes Distress: The Missing Piece of the Successful Type 1 Diabetes Management Puzzle.Standards of medical care in diabetes--2010.Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management The role of O-GlcNAc signaling in the pathogenesis of diabetic retinopathy.Current and future management of diabetic retinopathy: a personalized evidence-based approach.Musculoskeletal complications in type 1 diabetes.Oral Health Knowledge and Behaviors among Adolescents with Type 1 Diabetes.The cost-effectiveness of continuous glucose monitoring in type 1 diabetes.Diabetes management and glycemic control in youth with type 1 diabetes: test of a predictive model.Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease.Nephropathy in youth and young adults with type 2 diabetes Cumulative risk, age at onset, and sex-specific differences for developing end-stage renal disease in young patients with type 1 diabetes: a nationwide population-based cohort study.Basal insulin requirements on continuous subcutaneous insulin infusion during the first 12 months after diagnosis of type 1 diabetes mellitus.Blood glucose monitoring and glycemic control in adolescence: contribution of diabetes-specific responsibility and family conflict.Are individuals with diabetes seeing better?: a long-term epidemiological perspective.Targeting intensive versus conventional glycaemic control for type 1 diabetes mellitus: a systematic review with meta-analyses and trial sequential analyses of randomised clinical trials.Type 1 diabetes mellitus and cardiovascular disease: a scientific statement from the American Heart Association and American Diabetes Association.Impact of continuous glucose monitoring on quality of life, treatment satisfaction, and use of medical care resources: analyses from the SWITCH study

P2860

Q24186487-8AAA1DC2-C89E-49EA-9463-65C1297FCD2C Q24194881-20A0B990-8728-42D6-B637-32D2B2060CA1 Q24200376-C48F7948-C757-4B59-AA80-180192611773 Q24234960-719E3B93-54FF-4564-B7C8-606330D60A3A Q24632533-E47B2551-6777-4443-B6B6-E845CF2FBE38 Q26786057-77DC6228-09AC-42B7-975A-2667FB5D55E9 Q26795568-35426115-9519-4730-8174-253765480DE4 Q26799531-469345A4-90C0-4235-A34C-297E3154370E Q26865504-3221B50D-74F0-4C10-A101-166A501DD9C4 Q26996480-E38288B5-3782-481D-84B2-0092BFD9CE15 Q27000205-32A9A036-F40E-4433-A50D-F068CC2F05C1 Q27000491-350C793B-9A1A-4AEA-A830-EDA1B22692A3 Q27000603-2EBA3255-439A-4724-94DC-CC9A805735DF Q27012946-8A896DE5-F7D5-4831-8933-A320AC91C0B7 Q27014883-E3774872-3F3E-4AC5-BFAA-20E30B6736C8 Q27687598-65A60863-CD37-4A98-A61C-EBC98DC57344 Q29620309-FBF33EF4-3933-40BA-AA2C-7F00336840CB Q30244246-9AEFF744-40C1-4E2E-9715-F33056092232 Q30410405-544E6E75-8CF1-455F-BECE-52F537DA623A Q30542342-679F5DB9-320D-492A-ACC7-3E3A4908C6C1 Q30658906-A93300EA-85FB-45C8-8352-FC58CA2A7E17 Q31125904-0AA9C238-24AA-4B4A-85F7-094A041048A0 Q33361268-06B7DC0E-2CD6-413F-9008-DD0D4D966FFE Q33554238-F8E0516F-77D1-4295-A2C6-1FCBB3E14762 Q33621582-4FA55323-ACED-4C74-B96C-FCEEE538E66D Q33683197-62E083A3-BEB6-422F-A8BE-6D4D7406AE32 Q33738829-231EFABF-3569-4C3D-8FEC-26F6BE0C41E3 Q33793824-2FE525B2-0754-49E8-93F2-AE98B0530A83 Q33854068-1F85FF48-C0C3-47D1-B11E-E1E4DB5D0EC6 Q33873097-596BD378-3C6D-4B38-8967-C8B2238483F7 Q33880891-C99D0F09-0ECE-4EC7-95E2-86DDA4BF1540 Q33902878-8A022D9E-17C4-4FFD-A366-61D5A7A79640 Q33903763-22530A0C-22E7-4670-9EEF-B720B31AC6CF Q33930322-3327AE24-3096-474F-9D50-0212F7997104 Q33979688-B4BB5532-E355-413A-969A-B24F6A50F9E4 Q34008123-9C058FD5-C135-4066-B639-F1906B9A7C0F Q34024289-82E77ED8-7F27-41BE-A4FD-E502955ADB7E Q34071861-2E9F13CC-9D3A-4B9E-8611-D8E9CF362056 Q34219439-F7742499-4806-4F56-9FEF-3735B1E02110 Q34252778-0F1BE267-AA1E-4B6B-B99C-B0260F6705B6

P2860

Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (

Item

http://www.wikidata.org/entity/Q33835519

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu